LifeStance Health Group, Inc. (LFST)
Automate Your Wheel Strategy on LFST
With Tiblio's Option Bot, you can configure your own wheel strategy including LFST - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol LFST
- Rev/Share 3.3488
- Book/Share 3.8017
- PB 1.2021
- Debt/Equity 0.135
- CurrentRatio 1.4689
- ROIC -0.0061
- MktCap 1777163320.0
- FreeCF/Share 0.2671
- PFCF 17.3592
- PE -49.1498
- Debt/Assets 0.0935
- DivYield 0
- ROE -0.0247
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 4
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | LFST | UBS | Neutral | Buy | -- | $8.5 | May 27, 2025 |
| Initiation | LFST | KeyBanc Capital Markets | -- | Overweight | -- | $9 | April 8, 2025 |
| Initiation | LFST | Canaccord Genuity | -- | Buy | -- | $8 | April 3, 2025 |
| Upgrade | LFST | Goldman | Neutral | Buy | -- | $10 | Dec. 16, 2024 |
News
LifeStance: First Profit, Expanding Margins, And Hybrid Model Make It A Buy Despite Valuation Concerns
Published: July 03, 2025 by: Seeking Alpha
Sentiment: Positive
LifeStance Health is showing a real turnaround, posting its first-ever net profit and rapidly expanding margins, signaling operational discipline and scalable growth. The company's hybrid care model positions it well amid surging mental health demand, with strong revenue and clinician growth supporting its bullish outlook. Despite a mixed valuation and recent insider selling, institutional investors are accumulating shares, reflecting confidence in LifeStance's long-term margin expansion and platform potential.
Read More
LifeStance Health (LFST) Upgraded to Strong Buy: What Does It Mean for the Stock?
Published: June 27, 2025 by: Zacks Investment Research
Sentiment: Positive
LifeStance Health (LFST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Read More
After Plunging 9.9% in 4 Weeks, Here's Why the Trend Might Reverse for LifeStance Health (LFST)
Published: June 16, 2025 by: Zacks Investment Research
Sentiment: Negative
The heavy selling pressure might have exhausted for LifeStance Health (LFST) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Read More
Wall Street Analysts Think LifeStance Health (LFST) Could Surge 45.04%: Read This Before Placing a Bet
Published: June 05, 2025 by: Zacks Investment Research
Sentiment: Positive
The consensus price target hints at a 45% upside potential for LifeStance Health (LFST). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Read More
LifeStance Health (LFST) Upgraded to Strong Buy: Here's Why
Published: May 08, 2025 by: Zacks Investment Research
Sentiment: Positive
LifeStance Health (LFST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
Down -20.26% in 4 Weeks, Here's Why LifeStance Health (LFST) Looks Ripe for a Turnaround
Published: May 08, 2025 by: Zacks Investment Research
Sentiment: Positive
LifeStance Health (LFST) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Read More
LifeStance Health Group (LFST) Reports Break-Even Earnings for Q1
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Neutral
LifeStance Health Group (LFST) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.06 per share a year ago.
Read More
LifeStance Reports First Quarter 2025 Results
Published: May 07, 2025 by: GlobeNewsWire
Sentiment: Neutral
SCOTTSDALE, Ariz., May 07, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the first quarter ended March 31, 2025.
Read More
Wall Street Analysts Believe LifeStance Health (LFST) Could Rally 28.68%: Here's is How to Trade
Published: May 05, 2025 by: Zacks Investment Research
Sentiment: Positive
The mean of analysts' price targets for LifeStance Health (LFST) points to a 28.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Read More
LifeStance Health (LFST) Surges 5.8%: Is This an Indication of Further Gains?
Published: April 10, 2025 by: Zacks Investment Research
Sentiment: Positive
LifeStance Health (LFST) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Read More
LifeStance Health (LFST) Loses -13.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Published: March 21, 2025 by: Zacks Investment Research
Sentiment: Negative
LifeStance Health (LFST) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Read More
LifeStance Health Group, Inc. (LFST) Q4 2024 Earnings Call Transcript
Published: February 28, 2025 by: Seeking Alpha
Sentiment: Neutral
LifeStance Health Group, Inc. (NASDAQ:LFST ) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ET Company Participants Monica Prokocki - VP, IR Ken Burdick - CEO David Bourdon - CFO Conference Call Participants Craig Hettenbach - Morgan Stanley Lisa Gill - JPMorgan Jamie Perse - Goldman Sachs Brian Tanquilut - Jefferies Andrea Alfonso - UBS Operator Thank you for standing by. My name is Danielle, and I will be your conference operator today.
Read More
LifeStance Appoints Dave Bourdon as CEO; Ken Burdick Named Executive Chairman
Published: February 27, 2025 by: PRNewsWire
Sentiment: Neutral
Ryan McGroarty to Become Chief Financial Officer SCOTTSDALE, Ariz. , Feb. 27, 2025 /PRNewswire/ -- LifeStance Health Group, Inc. ("LifeStance" or the "Company") (Nasdaq: LFST), one of the nation's largest providers of outpatient mental health care, today announced that its Board of Directors has appointed Dave Bourdon as the Company's new Chief Executive Officer.
Read More
LifeStance Reports Fourth Quarter and Full Year 2024 Results
Published: February 27, 2025 by: GlobeNewsWire
Sentiment: Neutral
SCOTTSDALE, Ariz., Feb. 27, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the fourth quarter and full year ended December 31, 2024.
Read More
About LifeStance Health Group, Inc. (LFST)
- IPO Date 2021-06-10
- Website https://www.lifestance.com
- Industry Medical - Care Facilities
- CEO David Patrick Bourdon
- Employees 7535